Skip to content

Bill Schiffner

Dr. Reddy’s launches lenalidomide capsules

Dr. Reddy’s launches lenalidomide capsules

Dr. Reddy’s Laboratories announced the launch, in the U.S. market, of lenalidomide capsules, a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration. With this volume-limited launch, Dr.

Video Forum: Christine Baeder, Teva USA

Video Forum: Christine Baeder, Teva USA

Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them.

Video Forum: Todd Huseby, Kearney, Part 2

Video Forum: Todd Huseby, Kearney, Part 2

In the final installment of a two-part interview, Todd Huseby, a partner at Kearney and leader of the consulting firm’s consumer health care practice, tells this week’s Video Forum how such developments as the emergence of large health care ecosystems, the growing involvement of digitally based comp